Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • PrEP uptake poised to grow as physicians gain insight, stigmas fade

    Experts say some barriers that have led to a slow initial uptake in PrEP are beginning to crumble as more doctors learn about FTC/TDF and stigmas surrounding its use begin to fade.

    19 May 2016 | Infectious Disease News
  • NAT reaction to the Queen’s Speech 2016

    At the State Opening of Parliament today, the Queen announced a Bill “to ensure that overseas visitors pay for the health treatment they receive at public expense”. She also stated that proposals will be now be brought forward for a British Bill of Rights.

    18 May 2016 | NAT
  • The Hepatitis C Trust is considering seeking a judicial review of NHS England’s decision to ration access to hepatitis C treatment

    The Hepatitis C Trust wrote to NHS England to ask it to reconsider its decision to limit the number of people with hepatitis C who are allowed access to new NICE approved drugs that cure the disease. On Monday 16th May, 2016 NHS England replied with a response that The Hepatitis C Trust did not find satisfactory. With great regret it now has to consider seeking a judicial review of the decision.

    18 May 2016 | Hepatitis C Trust
  • HIV community gives 'Nul Points' Eurovision verdict to NHS England over PrEP delays

    The HIV community is uniting during Eurovision week to give a damning verdict on NHS England’s delays on PrEP (pre-exposure prophylaxis). The verdict is a resounding ‘Nul points’. The theme of Eurovision this year is ‘Come Together’, and community organisations and campaigners are coming together to make their message heard on social media. As the Eurovision Final approaches, PrEP supporters have begun tweeting NHS England with photos of themselves holding up ‘Nul points’ signs.

    14 May 2016 | prepaccess.org.uk
  • Philip Christopher Baldwin: “We need better access to treatment for gay men living with HIV and Hep C”

    I am saddened by the delay in the provision of Hep C treatment in the UK. Of the 103,700 people living with HIV in the UK, nine per cent are co-infected with Hep C, many of them gay men. It is unfair that we have to cope with Hep C without help. We have a treatment which can cure Hep C, but the treatment is being withheld by the NHS for funding reasons.

    11 May 2016 | Gay Times
  • If we want to end HIV, TB, and malaria, we need to do more to reduce human rights barriers

    A recent report from UNAIDS said that by 2020, countries should devote 8% of its HIV resources to reducing human rights barriers to accessing services. Currently, less than 1% of Global Fund grant funds is spent on programs to reduce human rights barriers. We have to do more and we have to do it better, says Ralf Jürgens. In this commentary, Ralf describes an intensive effort that the Global Fund is implementing in 15-20 countries, as well as other initiatives the Fund has planned.

    11 May 2016 | Global Fund Observer
  • Covering Costly HCV Tx: Who Makes that Call?

    Forcing U.S. states to cover pricey treatments for people with the hepatitis C virus (HCV) would cause the Medicaid budget to "explode," according to a Medicaid representative.

    11 May 2016 | MedPage Today HIV/AIDS
  • It’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments

    As consensus on the shortsightedness of insurance restrictions on life-saving hepatitis C treatments continues to build, it’s time for private insurers and Medicaid programs to give all Americans suffering from this devastating disease a chance at a cure.

    10 May 2016 | American Journal of Managed Care
  • A Way Out of the Dismal Arithmetic of Hepatitis C Treatment

    This special issue of The American Journal of Managed Care presents important new peer-reviewed research about the consequences of this dismal arithmetic of HCV treatment. The papers cover ground ranging from the out-of-pocket costs of a DAA treatment course to the real-world consequences—both economic and clinical—of failing to treat.

    10 May 2016 | American Journal of Managed Care
  • HIV in children is a symptom of the failures of the AIDS response

    Leaders from West and Central Africa urged to mobilize national and international political commitment for an ambitious catch up plan to intensify the HIV response in the region.

    10 May 2016 | MSF
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.